This year, President Obama has focused attention on treatments and tools that help doctors tailor medical care for individual patients. Research presented at the 2015 ASCO Annual Meeting shows how targeted therapies can be used to improve the care of people with a number of different types of blood cancer.
Hearing the word cancer is one of people’s biggest fears. In this guest post, Dr. Rick Boulay challenges everything you thought you knew about cancer and shares how he found hope after his wife was diagnosed with leukemia.
Recognizing the dramatic advances in the treatment of chronic lymphocytic leukemia (CLL), ASCO named the approval of four new drugs for this disease in 2014 as its first “Advance of the Year.”
Learn more about four studies that show the potential of new targeted therapies for advanced ovarian, lung, and thyroid cancers and chronic lymphocytic leukemia.